Jeffrey M Blaney

Title: The Innovative Contributions of Jeffrey M Blaney

Introduction

Jeffrey M Blaney is a notable inventor based in San Diego, CA. He has made significant contributions to the field of pharmaceuticals, particularly in the development of kinase modulators. His work has implications for the treatment of various diseases, showcasing his commitment to advancing medical science.

Latest Patents

Blaney holds a patent for "Substituted pyrrolopyridines and pyrazolopyridines as kinase modulators." This patent describes substituted pyrrolopyridine heterocycles and substituted pyrazolopyridine heterocycles, along with pharmaceutical compositions that include these heterocycles. The methods outlined in the patent focus on using these compounds in the treatment of diseases such as cancer, asthma, inflammation, and various other conditions. He has 1 patent to his name, reflecting his innovative approach to drug development.

Career Highlights

Blaney is associated with Sgx Pharmaceuticals, Inc., where he has contributed to the research and development of new therapeutic agents. His work at the company emphasizes the importance of kinase modulators in treating complex diseases, demonstrating his expertise in pharmaceutical innovation.

Collaborations

Throughout his career, Blaney has collaborated with notable colleagues, including Andreas Gosberg and Stefan N Gradl. These partnerships have likely enhanced his research efforts and contributed to the successful development of his patented inventions.

Conclusion

Jeffrey M Blaney's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his role as a significant inventor. His work continues to impact the treatment of various diseases, showcasing the importance of innovation in medical science.